2023 Q2 Form 10-Q Financial Statement

#000178217023000075 Filed on May 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $234.0M $203.9M $191.0M
YoY Change 48.82% 49.89% 41.24%
Cost Of Revenue $80.19M $74.07M $71.87M
YoY Change 31.83% 31.64% 27.35%
Gross Profit $153.8M $129.8M $119.2M
YoY Change 59.54% 62.76% 51.18%
Gross Profit Margin 65.74% 63.67% 62.38%
Selling, General & Admin $114.6M $105.5M $97.30M
YoY Change 16.66% 35.5% 29.96%
% of Gross Profit 74.47% 81.25% 81.65%
Research & Development $54.31M $49.38M $42.88M
YoY Change 50.51% 109.44% 124.19%
% of Gross Profit 35.3% 38.04% 35.99%
Depreciation & Amortization $3.187M $3.029M $1.854M
YoY Change 111.06% 101.93% 35.72%
% of Gross Profit 2.07% 2.33% 1.56%
Operating Expenses $172.1M $49.38M $142.0M
YoY Change 376.87% -52.03% 48.94%
Operating Profit -$18.22M -$28.07M -$22.87M
YoY Change -53.72% 21.12% 38.27%
Interest Expense $776.0K $389.0K $1.947M
YoY Change 133.73% -240.43% -1316.88%
% of Operating Profit
Other Income/Expense, Net -$1.546M -$1.511M $1.092M
YoY Change -191.64% -325.86% 1248.15%
Pretax Income -$18.99M -$27.94M -$19.83M
YoY Change -49.46% 22.66% 19.32%
Income Tax -$143.0K $370.0K -$434.0K
% Of Pretax Income
Net Earnings -$18.85M -$28.31M -$19.40M
YoY Change -50.71% 21.47% 17.01%
Net Earnings / Revenue -8.05% -13.89% -10.15%
Basic Earnings Per Share -$0.11 -$0.16
Diluted Earnings Per Share -$0.11 -$0.16 -$0.11
COMMON SHARES
Basic Shares Outstanding 177.9M shares 174.2M shares 170.7M shares
Diluted Shares Outstanding 179.1M shares 175.1M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $509.4M $452.4M $458.7M
YoY Change -13.54% -9.84% -12.28%
Cash & Equivalents $509.4M $244.2M $300.6M
Short-Term Investments
Other Short-Term Assets $30.85M $31.36M $19.33M
YoY Change 56.75% 33.95% 10.77%
Inventory
Prepaid Expenses $10.26M
Receivables
Other Receivables
Total Short-Term Assets $679.2M $606.9M $669.4M
YoY Change -3.54% 0.01% 10.18%
LONG-TERM ASSETS
Property, Plant & Equipment $25.10M $12.66M $11.55M
YoY Change 145.17% -25.29% 24.84%
Goodwill $54.94M $54.99M $0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.253M $6.863M $6.214M
YoY Change 74.76% 85.69% 77.04%
Total Long-Term Assets $105.4M $108.2M $26.53M
YoY Change 338.79% 424.48% 46.5%
TOTAL ASSETS
Total Short-Term Assets $679.2M $606.9M $669.4M
Total Long-Term Assets $105.4M $108.2M $26.53M
Total Assets $784.5M $715.2M $696.0M
YoY Change 7.75% 13.97% 11.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.61M $2.909M $6.794M
YoY Change 222.55% -51.9% 461.49%
Accrued Expenses $104.4M $79.48M $87.75M
YoY Change -8.46% 69.46% 31.6%
Deferred Revenue
YoY Change
Short-Term Debt $2.432M $2.490M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $226.7M $197.5M $209.1M
YoY Change -10.01% 31.15% 47.68%
LONG-TERM LIABILITIES
Long-Term Debt $34.00M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $8.134M $13.63M $1.050M
YoY Change 656.65% 149.31% 29.15%
Total Long-Term Liabilities $42.13M $13.63M $1.050M
YoY Change 3819.44% 149.31% 29.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $226.7M $197.5M $209.1M
Total Long-Term Liabilities $42.13M $13.63M $1.050M
Total Liabilities $268.8M $219.8M $215.9M
YoY Change 3.03% 40.84% 48.53%
SHAREHOLDERS EQUITY
Retained Earnings -$420.6M -$401.8M -$373.5M
YoY Change 31.04% 43.95%
Common Stock $18.00K $18.00K $17.00K
YoY Change 5.88% 6.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $515.7M $495.4M $480.1M
YoY Change
Total Liabilities & Shareholders Equity $784.5M $715.2M $696.0M
YoY Change 7.75% 13.97% 11.23%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$18.85M -$28.31M -$19.40M
YoY Change -50.71% 21.47% 17.01%
Depreciation, Depletion And Amortization $3.187M $3.029M $1.854M
YoY Change 111.06% 101.93% 35.72%
Cash From Operating Activities -$51.90M $433.0K -$77.35M
YoY Change 264.98% -98.92% 104.55%
INVESTING ACTIVITIES
Capital Expenditures $1.750M $864.0K $2.420M
YoY Change -212.54% -153.17% -294.22%
Acquisitions $40.93M
YoY Change
Other Investing Activities $0.00 -$40.93M $127.0K
YoY Change
Cash From Investing Activities -$1.750M -$43.09M -$2.293M
YoY Change 12.54% 2551.88% 84.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $17.07M
YoY Change
Cash From Financing Activities 36.79M -$13.64M 2.881M
YoY Change 1903.87% -624.3% -297.06%
NET CHANGE
Cash From Operating Activities -51.90M $433.0K -77.35M
Cash From Investing Activities -1.750M -$43.09M -2.293M
Cash From Financing Activities 36.79M -$13.64M 2.881M
Net Change In Cash -16.86M -$56.08M -76.76M
YoY Change 20.95% -236.03% 89.43%
FREE CASH FLOW
Cash From Operating Activities -$51.90M $433.0K -$77.35M
Capital Expenditures $1.750M $864.0K $2.420M
Free Cash Flow -$53.65M -$431.0K -$79.77M
YoY Change 323.61% -101.03% 118.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-2301143
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1111 Third Avenue,
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98101
CY2023Q1 dei City Area Code
CityAreaCode
888
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
736-4859
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
177948491 shares
CY2023Q1 us-gaap Settlement Assets Current
SettlementAssetsCurrent
123190000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6794000 usd
CY2023Q1 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
106947000 usd
CY2022Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
111075000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
79479000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
87752000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5642000 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
725000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
725000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
173250865 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
18000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-743000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-373463000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
495421000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
480087000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
695953000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
159188000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-28068000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-23174000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2024000 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
36000 usd
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175113904 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
175113904 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-23310000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
348000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
480087000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29775000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
348000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-23310000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3029000 usd
CY2023Q1 rely Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-1184000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4857000 usd
CY2023Q1 rely Increase Decrease In Settlement Liabilities
IncreaseDecreaseInSettlementLiabilities
-7448000 usd
CY2022Q1 rely Increase Decrease In Settlement Liabilities
IncreaseDecreaseInSettlementLiabilities
10257000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6841000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4362000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
244159000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
444605000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
498000 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
51000 usd
CY2023Q1 us-gaap Advertising Expense
AdvertisingExpense
34600000 usd
CY2023Q1 us-gaap Hosting Arrangement Service Contract Implementation Cost Capitalized After Accumulated Amortization
HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization
3000000 usd
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28814908 shares
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
0 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
19007000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
254292 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
19000000 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
12600000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.013
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16212000 usd
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2100
CY2023Q1 us-gaap Assets Current
AssetsCurrent
606938000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
99000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8675000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6863000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3521000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
203865000 usd
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
177733293 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
17000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-28314000 usd
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
164391753 shares
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1413000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-28314000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
471503000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4512000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-355000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13637000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
541000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
244657000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
444656000 usd
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Concentration of Credit Risk </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, disbursement prefunding, restricted cash, and customer funds receivable. The Company maintains cash and cash equivalents and restricted cash balances that may exceed the insured limits by the Federal Deposit Insurance Corporation. In addition, the Company funds its international operations using accounts with institutions in the major countries where its subsidiaries operate. The Company also prefunds amounts which are held by its disbursement partners, which are typically located in India, Mexico, and the Philippines. The Company has not experienced any significant losses on its deposits of cash and cash equivalents, disbursement prefunding, restricted cash, or customer funds receivable in the three months ended March 31, 2023 and 2022.</span></div>
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
833000 usd
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1068000 usd
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
500000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12658000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-28314000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-23310000 usd
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175113904 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
725000000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.11
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.60
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
9237232 shares
CY2022Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0 usd
CY2023Q1 rely Trade Settlement Liability
TradeSettlementLiability
14858000 usd
CY2023Q1 dei Entity File Number
EntityFileNumber
001-40822
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle,
CY2023Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
498000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12658000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6214000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
177733293 shares
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
897575000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
136014000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41408000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1517000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
313000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22782000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
370000 usd
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
164391753 shares
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27966000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2729000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
495421000 usd
CY2022Q1 rely Increase Decrease In Disbursement Prefunding
IncreaseDecreaseInDisbursementPrefunding
-62450000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12078000 usd
CY2022Q1 rely Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-807000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-969000 usd
CY2023Q1 us-gaap Payments For Software
PaymentsForSoftware
1296000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
40933000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2022Q1 us-gaap Stock Issued1
StockIssued1
1882000 usd
CY2022Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
327000 usd
CY2023Q1 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
170 country
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1108000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-275000 usd
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-144000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
33123000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
30063000 usd
CY2022Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
22300000 usd
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39460403 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.87
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
14091466 shares
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y6M25D
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29234000 usd
CY2022Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
0 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0 usd
CY2022Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0 usd
CY2023Q1 rely Accrued Transaction Expense
AccruedTransactionExpense
17015000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8840000 usd
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001782170
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Remitly Global, Inc.
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
RELY
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
244159000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
300635000 usd
CY2023Q1 rely Disbursement Prefunding Receivables Current
DisbursementPrefundingReceivablesCurrent
208228000 usd
CY2022Q4 rely Disbursement Prefunding Receivables Current
DisbursementPrefundingReceivablesCurrent
158055000 usd
CY2022Q4 us-gaap Settlement Assets Current
SettlementAssetsCurrent
191402000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
31361000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19327000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
669419000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11546000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12954000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
54989000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
0 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20285000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 usd
CY2023Q1 us-gaap Assets
Assets
715185000 usd
CY2022Q4 us-gaap Assets
Assets
695953000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2909000 usd
CY2023Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
2490000 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
197467000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
209142000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8665000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5674000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13632000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1050000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
219764000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
215866000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
173250865 shares
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
854276000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-395000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-401777000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
715185000 usd
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
44123000 usd
CY2022Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
40621000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49376000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23575000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23342000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3029000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
231933000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
389000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1511000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
669000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27944000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
528000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-23310000 usd
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-28314000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
4000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23306000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4993000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
6635000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
581000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
480328000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1882000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2678000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9921000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-23310000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-28314000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1517000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
29234000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
9594000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1083000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-83000 usd
CY2023Q1 rely Increase Decrease In Disbursement Prefunding
IncreaseDecreaseInDisbursementPrefunding
44157000 usd
CY2023Q1 rely Increase Decrease In Settlement Assets
IncreaseDecreaseInSettlementAssets
-69608000 usd
CY2022Q1 rely Increase Decrease In Settlement Assets
IncreaseDecreaseInSettlementAssets
14453000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6221000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
433000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
40250000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
864000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
872000 usd
CY2022Q1 us-gaap Payments For Software
PaymentsForSoftware
753000 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-43093000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1625000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4844000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2601000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1413000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
17068000 usd
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2601000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
219000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-56078000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
41343000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
300735000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
403313000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
244657000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
444656000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
341000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
227000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
124000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
605000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5414000 usd
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2830000 usd
CY2023Q1 rely Vesting Of Early Exercised Options
VestingOfEarlyExercisedOptions
149000 usd
CY2022Q1 rely Vesting Of Early Exercised Options
VestingOfEarlyExercisedOptions
205000 usd
CY2023Q1 us-gaap Stock Issued1
StockIssued1
2729000 usd
CY2023Q1 rely Stock Issued Acquisition Consideration
StockIssuedAcquisitionConsideration
6635000 usd
CY2022Q1 rely Stock Issued Acquisition Consideration
StockIssuedAcquisitionConsideration
0 usd
CY2023Q1 rely Issuance Of Unvested Common Stock Subject To Service Based Vesting Conditions In Connection With Acquisition
IssuanceOfUnvestedCommonStockSubjectToServiceBasedVestingConditionsInConnectionWithAcquisition
581000 usd
CY2022Q1 rely Issuance Of Unvested Common Stock Subject To Service Based Vesting Conditions In Connection With Acquisition
IssuanceOfUnvestedCommonStockSubjectToServiceBasedVestingConditionsInConnectionWithAcquisition
0 usd
CY2023Q1 rely Business Combination Consideration Transferred Amount Held Back
BusinessCombinationConsiderationTransferredAmountHeldBack
11899000 usd
CY2022Q1 rely Business Combination Consideration Transferred Amount Held Back
BusinessCombinationConsiderationTransferredAmountHeldBack
0 usd
CY2023Q1 rely Business Combination Consideration Transferred Pre Existing Receivable Settlement
BusinessCombinationConsiderationTransferredPreExistingReceivableSettlement
2401000 usd
CY2022Q1 rely Business Combination Consideration Transferred Pre Existing Receivable Settlement
BusinessCombinationConsiderationTransferredPreExistingReceivableSettlement
0 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
Use of Estimates The preparation of the accompanying Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed within the Condensed Consolidated Financial Statements and accompanying notes. These estimates and assumptions include, but are not limited to, revenue recognition including the treatment of sales incentive programs, reserves for transaction losses, stock-based compensation expense, the carrying value of operating lease right-of-use assets, the recoverability of deferred tax assets, capitalization of software development costs, goodwill, and the recoverability of intangible assets. The key assumptions applied for the intangible assets include forecasted revenue and growth rates for a hypothetical market participant, selected discount rates, as well as migration curves for developed technology. The Company bases its estimates on historical experience and on assumptions that management considers reasonable. Actual results could differ from these estimates and assumptions, and these differences could be material to the Condensed Consolidated Financial Statements.
CY2022Q1 us-gaap Advertising Expense
AdvertisingExpense
34500000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1212000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
600000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
203865000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
136014000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20465000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18517000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11546000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
1800000 usd
CY2022Q1 us-gaap Depreciation
Depreciation
1500000 usd
CY2023Q1 rely Hosting Arrangement Service Contract Implementation Cost Capitalized Additions
HostingArrangementServiceContractImplementationCostCapitalizedAdditions
900000 usd
CY2022Q1 rely Hosting Arrangement Service Contract Implementation Cost Capitalized Additions
HostingArrangementServiceContractImplementationCostCapitalizedAdditions
400000 usd
CY2023Q1 us-gaap Hosting Arrangement Service Contract Implementation Cost Expense Amortization
HostingArrangementServiceContractImplementationCostExpenseAmortization
400000 usd
CY2022Q1 us-gaap Hosting Arrangement Service Contract Implementation Cost Expense Amortization
HostingArrangementServiceContractImplementationCostExpenseAmortization
100000 usd
CY2022Q4 us-gaap Hosting Arrangement Service Contract Implementation Cost Capitalized After Accumulated Amortization
HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization
2500000 usd
CY2023Q1 us-gaap Hosting Arrangement Service Contract Implementation Cost Expense Amortization
HostingArrangementServiceContractImplementationCostExpenseAmortization
351000 usd
CY2022Q1 us-gaap Hosting Arrangement Service Contract Implementation Cost Expense Amortization
HostingArrangementServiceContractImplementationCostExpenseAmortization
119000 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1200000 usd
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2023Q1 us-gaap Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual
BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
3200000 usd
CY2023Q1 us-gaap Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual
BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
-8500000 usd
CY2023Q1 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
0 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
21500000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1215000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20285000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
3644000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
4858000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4858000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4525000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2400000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20285000 usd
CY2023Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
27300000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
175113904 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
164391753 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
164391753 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2023Q1 rely Common Stock Voting Rights Votes
CommonStockVotingRightsVotes
1 vote
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
0 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
15988268 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M14D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
119467000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1659193 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14074783 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.23
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M21D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
179001000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.60
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y9M21D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
132531000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.24
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
179038000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2200000 usd
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2900000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9594000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
0 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0 usd
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.023
CY2022Q4 rely Trade Settlement Liability
TradeSettlementLiability
26266000 usd
CY2023Q1 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
760000 usd
CY2022Q4 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
1926000 usd
CY2022Q4 rely Accrued Transaction Expense
AccruedTransactionExpense
15878000 usd
CY2023Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
11907000 usd
CY2022Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
11394000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4026000 usd
CY2023Q1 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
10901000 usd
CY2022Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
8288000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12129000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
79479000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
87752000 usd

Files In Submission

Name View Source Status
0001782170-23-000075-index-headers.html Edgar Link pending
0001782170-23-000075-index.html Edgar Link pending
0001782170-23-000075.txt Edgar Link pending
0001782170-23-000075-xbrl.zip Edgar Link pending
a102yoakumrestatedofferlet.htm Edgar Link pending
a103sinharestatedofferlett.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
rely-20230331.htm Edgar Link pending
rely-20230331.xsd Edgar Link pending
rely1q23-exhibit311.htm Edgar Link pending
rely1q23-exhibit312.htm Edgar Link pending
rely1q23-exhibit321.htm Edgar Link pending
rely1q23-exhibit322.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
rely-20230331_cal.xml Edgar Link unprocessable
rely-20230331_def.xml Edgar Link unprocessable
rely-20230331_lab.xml Edgar Link unprocessable
rely-20230331_pre.xml Edgar Link unprocessable
rely-20230331_htm.xml Edgar Link completed